These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30678909)

  • 1. A new lipid-based oral delivery system of erythromycin for prolong sustain release activity.
    Momoh MA; Ossai EC; Chidozie OE; Precscila OO; Kenechukwu FC; Ofokansi KO; Attama AA; Olobayo KO
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():245-253. PubMed ID: 30678909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation in vitro and in vivo evaluation of SRMS-based heterolipid-templated homolipid delivery system for diclofenac sodium.
    Mumuni M; Attama AA; Kunle OO
    Drug Deliv; 2016; 23(3):917-25. PubMed ID: 24959939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid micro-dispersions (SLMs) based on PEGylated solidified reverse micellar solutions (SRMS): a novel carrier system for gentamicin.
    Kenechukwu FC; Momoh MA; Nnamani PO; Attama AA
    Drug Deliv; 2015; 22(6):710-22. PubMed ID: 24724962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release diclofenac potassium-loaded solid lipid microparticle based on solidified reverse micellar solution: in vitro and in vivo evaluation.
    Chime SA; Attama AA; Builders PF; Onunkwo GC
    J Microencapsul; 2013; 30(4):335-45. PubMed ID: 23057661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of novel solid lipid microparticles loaded with gentamicin and its evaluation in vitro and in vivo.
    Umeyor EC; Kenechukwu FC; Ogbonna JD; Chime SA; Attama A
    J Microencapsul; 2012; 29(3):296-307. PubMed ID: 22283701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design, in vitro characterizations and anti-malarial investigations of artemether and lumefantrine-entrapped solid lipid microparticles.
    Agbo C; Umeyor C; Kenechukwu F; Ogbonna J; Chime S; Lovelyn C; Agubata O; Ofokansi K; Attama A
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1708-21. PubMed ID: 27095388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus.
    Nnamani PO; Attama AA; Kenechukwu FC; Ibezim EC; Adikwu MU
    Curr Drug Deliv; 2013 Dec; 10(6):645-55. PubMed ID: 23140234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
    Momoh MA; Kenechukwu FC; Attama AA
    Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin.
    Hooda A; Sradhanjali M; Popsy
    Pharm Nanotechnol; 2017; 5(4):329-341. PubMed ID: 29278216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
    Girotra P; Singh SK
    AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro evaluation of a PEGylated microscopic lipospheres delivery system for ceftriaxone sodium.
    Attama AA; Okafor CE; Builders PF; Okorie O
    Drug Deliv; 2009 Nov; 16(8):448-57. PubMed ID: 19839789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment.
    Kenechukwu FC; Nnamani DO; Duhu JC; Nmesirionye BU; Momoh MA; Akpa PA; Attama AA
    Heliyon; 2022 Mar; 8(3):e09099. PubMed ID: 35309393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel solidified reverse micellar solution-based mucoadhesive nano lipid gels encapsulating miconazole nitrate-loaded nanoparticles for improved treatment of oropharyngeal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC
    J Microencapsul; 2017 Sep; 34(6):592-609. PubMed ID: 28877639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids.
    Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC
    Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, characterization and pharmacokinetics of mupirocin-loaded nanostructured lipid carriers (NLCs) for intravascular administration.
    Alcantara KP; Zulfakar MH; Castillo AL
    Int J Pharm; 2019 Nov; 571():118705. PubMed ID: 31536765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
    Arregui JR; Kovvasu SP; Betageri GV
    AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
    Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
    Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics.
    Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.